Tags

Type your tag names separated by a space and hit enter

Drug-usage evaluation by disease state: developing protocols.
Pharm Pract Manag Q. 1996 Jul; 16(2):18-25.PP

Abstract

The Joint Commission definition of drug-usage evaluation (DUE) also applies to DUE by disease state. The criteria for disease process selection, key processes being evaluated, methods to develop initial DUE protocols, and DUE validation and approval processes are reviewed. The treatment of community-acquired pneumonia is a disease state DUE performed at Saint Joseph Health Center in Kansas City, Missouri. The preliminary protocol was developed by a collaborative network of clinical pharmacists in the metropolitan area. Outcome measures were included in the evaluation. The results were used as baseline data in the development of a pneumonia clinical pathway.

Authors+Show Affiliations

Enlow ML
Saint Joseph Health Center, Kansas City, MO, USA.

MeSH

Community-Acquired InfectionsCritical PathwaysDisease ProgressionDrug Utilization ReviewForms and Records ControlHospitals, ReligiousHumansJoint Commission on Accreditation of Healthcare OrganizationsMissouriOutcome Assessment, Health CarePharmacy Service, HospitalPneumoniaUnited States

Pub Type(s)

Journal Article

Language

eng

PubMed ID

10161607

Citation

Enlow, M L.. "Drug-usage Evaluation By Disease State: Developing Protocols." Pharmacy Practice Management Quarterly, vol. 16, no. 2, 1996, pp. 18-25.
Enlow ML. Drug-usage evaluation by disease state: developing protocols. Pharm Pract Manag Q. 1996;16(2):18-25.
Enlow, M. L. (1996). Drug-usage evaluation by disease state: developing protocols. Pharmacy Practice Management Quarterly, 16(2), 18-25.
Enlow ML. Drug-usage Evaluation By Disease State: Developing Protocols. Pharm Pract Manag Q. 1996;16(2):18-25. PubMed PMID: 10161607.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Drug-usage evaluation by disease state: developing protocols. A1 - Enlow,M L, PY - 1996/6/6/pubmed PY - 1996/6/6/medline PY - 1996/6/6/entrez SP - 18 EP - 25 JF - Pharmacy practice management quarterly JO - Pharm Pract Manag Q VL - 16 IS - 2 N2 - The Joint Commission definition of drug-usage evaluation (DUE) also applies to DUE by disease state. The criteria for disease process selection, key processes being evaluated, methods to develop initial DUE protocols, and DUE validation and approval processes are reviewed. The treatment of community-acquired pneumonia is a disease state DUE performed at Saint Joseph Health Center in Kansas City, Missouri. The preliminary protocol was developed by a collaborative network of clinical pharmacists in the metropolitan area. Outcome measures were included in the evaluation. The results were used as baseline data in the development of a pneumonia clinical pathway. SN - 1080-5737 UR - https://www.unboundmedicine.com/medline/citation/10161607/Drug_usage_evaluation_by_disease_state:_developing_protocols_ L2 - https://medlineplus.gov/pneumonia.html DB - PRIME DP - Unbound Medicine ER -